Skip to main navigation
Advancing Diagnostics to Improve Cancer Treatments Navigation
  • Products
  • Technology
  • Partnership Opportunities
  • Company
  • Contact

Investor Relations

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Corporate Governance
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Email Alerts Subscription
  • Download Library
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

SEC Filing Details

Document Details

Form
10-K
Filing Date
Apr 5, 2022
Document Date
Dec 31, 2021
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Biocept Inc.
Issuer
BIOCEPT INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Investor Relations Company Careers Customer Service
Contact Biocept, Inc.

Biocept, Inc. Headquarters
9955 Mesa Rim Road
San Diego, CA 92121
Phone: 858.320.8200
Fax: 858.320.8225
Email: IR@biocept.com

LHA Investor Relations
Jody Cain
310.691.7107
jcain@lhai.com


  • Careers
  • Company
  • Technology
  • Privacy Policy
  • Terms of Use
  • Contact Us

© 2023 Biocept, Inc. All rights reserved.